2013
DOI: 10.4172/2153-2435.s2-004
|View full text |Cite
|
Sign up to set email alerts
|

Facile and Manifest Liquid Chromatographic Method for the Simultaneous Determination of Enalpril Maleate and NSAIDs in API and Pharmaceutical Formulations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
4

Relationship

4
0

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Effluents from the column were monitored at 225nm. [17] ACE inhibitors alone are not sufficient to decrease high blood pressure hence, they are used in as combination with other particular classes of drug compounds such as calcium channel blocker antihypertensives, diuretics, and etc another method is reported of enalapril with diuretic Hydrochlorothiazide and Furosemide in Active Pharmaceutical Ingredients, Pharmaceutical Dosage Forms and Human Serum [18]. Simultaneous LC determination of, lisinopril, rosuvastatin, captopril, and enalapril in API, pharmaceutical dosage formulations, and human serum [19] other methods of enalapril with hypoglycemics (glibenclamide .metformin, glimepride) statins and H2 receptor antagonist in bulk, formulations and human serum by RP-HPLC [20][21][22] are reported (Figure 1).…”
Section: Methods Of Assaymentioning
confidence: 99%
“…Effluents from the column were monitored at 225nm. [17] ACE inhibitors alone are not sufficient to decrease high blood pressure hence, they are used in as combination with other particular classes of drug compounds such as calcium channel blocker antihypertensives, diuretics, and etc another method is reported of enalapril with diuretic Hydrochlorothiazide and Furosemide in Active Pharmaceutical Ingredients, Pharmaceutical Dosage Forms and Human Serum [18]. Simultaneous LC determination of, lisinopril, rosuvastatin, captopril, and enalapril in API, pharmaceutical dosage formulations, and human serum [19] other methods of enalapril with hypoglycemics (glibenclamide .metformin, glimepride) statins and H2 receptor antagonist in bulk, formulations and human serum by RP-HPLC [20][21][22] are reported (Figure 1).…”
Section: Methods Of Assaymentioning
confidence: 99%
“…Taking this into account we have worked on a number of in vitro interactions of enalapril with hypoglycemic agents 14 Lefunomide with NSAIDs 15 , enalapril maleate and H 2 -receptor antagonists 16 . To quantitate these interactions we reported simple and economical HPLC-UV methods for the quantitation of these drugs alone 17 as well as in combinations 18,19 .Diabetic patients who take a combination of medications especially NSAIDS are prone to drug interactions, so it is necessary to study these interactions with respect to the pharmacokinetics of the combined dosage forms. Thus our research group reported a number of in vivo interactions of NSAIDS with leflunomide 20 , as well as hypoglycemic agents 21,22 on Carrageenan Induced Inflammations.…”
Section: Enalapril Maleate Chemically Described As (S)-1-[n-[1-(ethoxmentioning
confidence: 99%
“…We reported a method to quantitate enalapril with NSAIDs simultaneously using high performance liquid chromatography (HPLC)-UV technique which was used to study the in vitro interactions [10].…”
Section: A Rt I C L E I N F O Abstractmentioning
confidence: 99%